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Abstract
Inhalation of fine particulate matter (<2.5 μm; fine PM) has been shown to increase the risk for cardiovascular
events. In this letter, we reappraise the role of tissue factor (TF) antigen and we also summarize changes in
measured coagulation proteins in humans and rodents by other studies with fine PM. By considering all studies
including ours, we conclude that monitoring the overall coagulation state by measuring capacity assays such as
thrombin generation, and quantification of TF activity would be more suitable than determining single coagulation
proteins (such as TF antigen) in order to better assess the systemic prothrombotic effects of fine PM.
Blood coagulation markers and fine PM exposure
studies
Evren Kilinç, Gerhardus JAJM Kuiper, Henri MH
Spronk, Hugo ten Cate
Earlier epidemiologic and experimental studies have
shown that fine particulate matter (<2.5 μm; fine PM)
inhalation is associated with arterial and venous thrombo-
sis, as well as an increased risk for cardiovascular death
[1]. Several studies have addressed the possible mechan-
isms involved in PM-related arterial and venous thrombo-
sis, although the recently published work by Emmerechts
et al. could not establish a direct effect of intratracheal PM
instillation on induction of venous thrombosis in mice [2].
Tissue factor (TF) is expressed in subendothelial cells
upon injury, or on the surface of cells like monocytes,
macrophages and neutrophils. A small amount of TF is
necessary to form a complex with factor VIIa to produce
thrombin via the extrinsic pathway of coagulation [3].
Since PM is also related to endothelial damage and
activation of platelets and macrophages upon short term
in vivo exposure [1], the measurement of TF in blood may
be considered as a marker of cell damage.
A recent publication in this journal, addressed the
effects of ambient fine PM in spontaneously hypertensive
rats (SHRs) following intratracheal instillation at varying
concentrations. Surprisingly, an early decrease in lung
specific tissue factor (TF) antigen was observed at 1 and
3 days post exposure, whereas plasminogen activator
inhibitor-1 (PAI-1) was increased at 1 day post instilla-
tion of fine PM [4].
It is known that a small proportion of TF exerts pro-
thrombotic effects and the inactive form of TF may not
reflect TF activity [3]. Additionally, tissue factor pathway
inhibitor (TFPI), the physiological inhibitor of TF, regu-
lates TF activity. Therefore, the measurements of TF anti-
gen in tissues do not necessarily reflect the functional
capacity and integrity of TF. Overall, measuring TF activity
could be a better approach for determining procoagulant
activity in tissues (local effect) and plasma (systemic effect).
Indeed, we recently showed that short-term inhalation
of fine PM increased lung specific TF activity at 4 and
48 hours post instillation as well as the overall procoagu-
lant potential of lung tissue, as assessed by thrombin gen-
eration, most likely through attenuated expression and
activity of the natural anticoagulant thrombomodulin [5].
In addition to rodent studies [6], different single coa-
gulation proteins have also been measured in humans
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exposed to fine PM [7-11]. The outcome of such studies
is rather inconsistent however, either with changes, or
no change in the levels of coagulation proteins, such as
factor VII (FVII), FVIII, FIX, FX. The specific responses
being most likely related to differences in fine PM
source and the dose used, as well as the time course of
sample collection and the experimental setup. At the
same time, it is likely that possible procoagulant reac-
tions to acute PM exposure will be downplayed by an
increased anticoagulant response as a systemic protec-
tive mechanism. Therefore, the balance in pro- and
anticoagulant reactions to PM will modulate the net
thrombotic events via thrombin, which is the critical
enzyme regulating the final common pathway leading to
fibrin formation [5].
In further studies of prothrombotic mechanisms of
PM, either after acute or chronic exposure, we would
advocate the use of overall capacity assays such as for
thrombin generation, in conjunction with TF activity
and specific anticoagulant proteins in order to better
understand the net contribution of fine PM to thrombo-
tic and cardiovascular events.
Response to Kilinç et al
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We appreciate the comments from Kilinç and coworkers
concerning application and interpretation of blood coagu-
lation markers in PM exposure studies. They suggest the
application of capacity assays rather than measurements of
single coagulation factors to better understand alterations
of the coagulation homeostasis in PM exposure studies.
With respect to our study [4], the functional activity of TF
in target organs would have been more suitable than mea-
surement of the antigen level in tissues. We agree with
Kilinç et al. that TF activity or even further coagulation
assays would certainly improve our understanding of the
complex response observed in our PM2.5 Augsburg
(PM2.5-AB) exposure study. Reliable activity assays evalu-
ated in correspondence to their protein/transcription
levels always provide essential functional information of
biological responses. However, our study was designed to
get a global impression of PM2.5-AB associated inflamma-
tory and cardiovascular effects in target organs and their
potential interactions rather than being specifically focused
on disturbances of the coagulation cascade. Related to
thrombogenic effects reported after PM exposures
[6,10,12-16], we selected TF and PAI-1 as representative
markers to assess deteriorations of the coagulation home-
ostasis. Increased levels of TF and PAI-1 were observed in
the heart three days after exposure to high PM2.5-AB.
This is in line with the common understanding that
inflammatory activity - as evidenced in our study by
increased levels of osteopontin and macrophage inflamma-
tory protein (MIP)2 in the heart and C- reactive protein
(CRP) in the serum - triggers TF mediated coagulation
[17]. The scenario observed in the lung appears to be
more complex, an early inflammatory response at day 1 is
associated with a reduced TF and an increased PAI-1 level
while at day 3 both markers, in particular PAI-1, were sub-
stantially down regulated. Most inflammatory markers
reached baseline levels at this time point [4]. Our data
indicate that PM2.5-AB exposure alters the coagulation
homeostasis in lungs and heart and shows that main target
organs exhibit a different response with respect to time
course and direction. As already mentioned by Kilinç et al.
these results are principally in line with reports from other
studies whereby differences in the PM source, the route of
administration, and the dose may explain the different
outcomes described so far with respect to the endpoints
selected. Indeed, uncovering the underlying pathomechan-
isms of PM2.5-AB associated effects on the homeostasis of
blood coagulation warrants further investigation and
would require the assessment of platelet function, major
pro- and anticoagulant pathways and may be even the
bidirectional interaction between inflammation and coagu-
lation [17]. It remains a task to specifically address this
issue by assessing protein levels and functional activity for
a set of key coagulation events including the assessment of
the tissue factor thrombomodulin balance and fibrin for-
mation as suggested by Kilinç et al.
Acknowledgements and funding
EK granted by the Netherlands Heart Foundation (grant number: 2006B064).
Author details
1Department of Internal Medicine, Laboratory for Clinical Thrombosis and
Haemostasis, Cardiovascular Research Institute Maastricht, Maastricht
University Medical Center, P.O. Box 616, UNS 50: Box 8, 6200 MD, Maastricht,
The Netherlands. 2Institute of Epidemiology I, Helmholtz Zentrum München,
German Research Center for Environmental Health, Ingolstaedter Landstrasse
1, D85764, Neuherberg/Munich, Germany. 3Institute of Epidemiology II,
Helmholtz Zentrum München, German Research Center for Environmental
Health, Ingolstaedter Landstrasse 1, D85764, Neuherberg/Munich, Germany.
4Comprehensive Pneumology Center, Institute of Lung Biology and Disease,
Helmholtz Zentrum München, German Research Center for Environmental
Health, Ingolstaedter Landstrasse 1, D85764, Neuherberg/Munich, Germany.
5Institute of Health Economics and Health Care Management, Helmholtz
Zentrum München, German Research Center for Environmental Health,
Ingolstaedter Landstrasse 1, D85764, Neuherberg/Munich, Germany. 6Focus
Network Nanoparticles and Health, Helmholtz Zentrum München, German
Research Center for Environmental Health, Ingolstaedter Landstrasse 1,
D85764, Neuherberg/Munich, Germany. 7Department of Environmental and
Occupational Health, Graduate School of Public Health, University of
Pittsburgh, PA, Bridge Side Point; 100 Technology Drive, Pittsburgh, 15219
PA, USA.
Authors’ contributions
EK, HS, GJAJMK, HMHS, HtC, SU, KG, TS, MSB, ST, WGK, MP, PR, AP, OE, HEW
all equally contributed to writing this manuscript and approved the final
version.
Kilinç et al. Particle and Fibre Toxicology 2011, 8:12
http://www.particleandfibretoxicology.com/content/8/1/12
Page 2 of 3
Competing interests
The authors declare that they have no competing interests.
Received: 14 January 2011 Accepted: 15 March 2011
Published: 15 March 2011
References
1. Brook RD, Rajagopalan S, Pope CA, Brook JR, Bhatnagar A, Diez-Roux AV,
Holguin F, Hong Y, Luepker RV, Mittleman MA, et al: Particulate matter air
pollution and cardiovascular disease: An update to the scientific
statement from the American Heart Association. Circulation 2010,
121(21):2331-2378.
2. Emmerechts J, Alfaro-Moreno E, Vanaudenaerde BM, Nemery B,
Hoylaerts MF: Short-term exposure to particulate matter induces arterial
but not venous thrombosis in healthy mice. J Thromb Haemost 2010,
8(12):2651-2661.
3. Breitenstein A, Tanner FC, Luscher TF: Tissue factor and cardiovascular
disease: quo vadis? Circ J 2010, 74(1):3-12.
4. Upadhyay S, Ganguly K, Stoeger T, Semmler-Bhenke M, Takenaka S,
Kreyling WG, Pitz M, Reitmeir P, Peters A, Eickelberg O, et al: Cardiovascular
and inflammatory effects of intratracheally instilled ambient dust from
Augsburg, Germany, in spontaneously hypertensive rats (SHRs). Part Fibre
Toxicol 2010, 7:27.
5. Frederix K, Kooter IM, van Oerle R, Fens D, Hamulyak K, Gerlofs-Nijland ME,
Ten Cate H, Spronk HM: A new method to determine tissue specific
tissue factor thrombomodulin activities: endotoxin and particulate air
pollution induced disbalance. Thromb J 2008, 6:14.
6. Nadziejko C, Fang K, Chen LC, Cohen B, Karpatkin M, Nadas A: Effect of
concentrated ambient particulate matter on blood coagulation
parameters in rats. Res Rep Health Eff Inst 2002, , 111: 7-29, discussion 31-
28.
7. Barregard L, Sallsten G, Gustafson P, Andersson L, Johansson L, Basu S,
Stigendal L: Experimental exposure to wood-smoke particles in healthy
humans: effects on markers of inflammation, coagulation, and lipid
peroxidation. Inhal Toxicol 2006, 18(11):845-853.
8. Brauner EV, Moller P, Barregard L, Dragsted LO, Glasius M, Wahlin P,
Vinzents P, Raaschou-Nielsen O, Loft S: Exposure to ambient
concentrations of particulate air pollution does not influence vascular
function or inflammatory pathways in young healthy individuals. Part
Fibre Toxicol 2008, 5:13.
9. Chuang KJ, Chan CC, Su TC, Lee CT, Tang CS: The effect of urban air
pollution on inflammation, oxidative stress, coagulation, and autonomic
dysfunction in young adults. Am J Respir Crit Care Med 2007,
176(4):370-376.
10. Riediker M, Devlin RB, Griggs TR, Herbst MC, Bromberg PA, Williams RW,
Cascio WE: Cardiovascular effects in patrol officers are associated with
fine particulate matter from brake wear and engine emissions. Part Fibre
Toxicol 2004, 1(1):2.
11. Schneider A, Neas LM, Graff DW, Herbst MC, Cascio WE, Schmitt MT,
Buse JB, Peters A, Devlin RB: Association of cardiac and vascular changes
with ambient PM2.5 in diabetic individuals. Part Fibre Toxicol 2010, 7:14.
12. Khandoga A, Stampfl A, Takenaka S, Schulz H, Radykewicz R, Kreyling W,
Krombach F: Ultrafine particles exert prothrombotic but not
inflammatory effects on the hepatic microcirculation in healthy mice in
vivo. Circulation 2004, 109(10):1320-1325.
13. Kodavanti UP, Schladweiler MC, Ledbetter AD, Hauser R, Christiani DC,
McGee J, Richards JR, Costa DL: Temporal association between pulmonary
and systemic effects of particulate matter in healthy and cardiovascular
compromised rats. J Toxicol Environ Health A 2002, 65(20):1545-1569.
14. Nemmar A, Hoylaerts MF, Hoet PH, Nemery B: Possible mechanisms of the
cardiovascular effects of inhaled particles: systemic translocation and
prothrombotic effects. Toxicol Lett 2004, 149(1-3):243-253.
15. Nemmar A, Nemery B, Hoet PH, Vermylen J, Hoylaerts MF: Pulmonary
inflammation and thrombogenicity caused by diesel particles in
hamsters: role of histamine. Am J Respir Crit Care Med 2003,
168(11):1366-1372.
16. Upadhyay S, Stoeger T, Harder V, Thomas RF, Schladweiler MC, Semmler-
Behnke M, Takenaka S, Karg E, Reitmeir P, Bader M, et al: Exposure to
ultrafine carbon particles at levels below detectable pulmonary
inflammation affects cardiovascular performance in spontaneously
hypertensive rats. Part Fibre Toxicol 2008, 5:19.
17. Levi M: The coagulant response in sepsis and inflammation.
Hamostaseologie 2010, 30(1):10-12, 14-16.
doi:10.1186/1743-8977-8-12
Cite this article as: Kilinç et al.: The procoagulant effects of fine
particulate matter in vivo. Particle and Fibre Toxicology 2011 8:12.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Kilinç et al. Particle and Fibre Toxicology 2011, 8:12
http://www.particleandfibretoxicology.com/content/8/1/12
Page 3 of 3
